Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Amparore

Showing results (1-10 of 319) with videos related to

Pageof 32
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|November 5, 2021
Editorial Comment to Randomized trials to determine the ideal management of the renal artery during partial nephrectomy: Life's under no obligation to give us what we expectRiccardo Campi, Daniele Amparore,
The Lancet. Oncology|May 4, 2023
Fluorescence in prostate cancer surgeryDaniele Amparore, Francesco Porpiglia
Asian Journal of Urology|February 1, 2023
Reply to Grange PC, Morris PT, Benz HL, Buggele WA, Fryrear RS. Letter to the editor re: Amparore D, Pecoraro A, Piramide F, Verri P, Checcucci E, De Cillis S, et al. Three-dimensional imaging reconstruction of the kidney's anatomy for a tailored minimally invasive partial nephrectomy: A pilot study. Asian J Urol 2022;9:263-71. A further step towards personalized surgery through virtual clip applicationAngela Pecoraro, Daniele Amparore
Nature Reviews. Urology|April 29, 2026
Adjuvant immunotherapy for renal cell carcinoma: understanding complexity, embracing uncertainty, making a differenceRiccardo Campi, Daniele Amparore,
European Urology|October 17, 2019
Re: Partial Nephrectomy Versus Radical Nephrectomy for cT2 or Greater Renal Tumors: A Systematic Review and Meta-analysisFrancesco Porpiglia, Daniele Amparore
Current Opinion in Urology|August 3, 2013
Treatment outcomes of partial nephrectomy for T1b tumoursAlessandro Volpe, Daniele Amparore, Alexandre Mottrie
Minerva Urology and Nephrology|September 25, 2024
YAU Renal Cancer spotlight - Hugo RAS platform for robotic partial nephrectomy: more evidence neededRiccardo Bertolo, Riccardo Campi, Daniele Amparore, et al.
Minerva Urology and Nephrology|June 18, 2025
YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trialVeronica Mollica, Riccardo Campi, Daniele Amparore, et al.
Minerva Urology and Nephrology|June 18, 2025
YAU renal cancer SPOTLIGHT: the understated challenge of tumor rupture during robotic partial nephrectomyRiccardo Bertolo, Riccardo Campi, Daniele Amparore, et al.
European Urology Oncology|March 25, 2026
Re: Blackmur JP, Rossi SH, Kuusk T, et al. Prediction Models for Shared Decision-making by Patients with Localised Renal Masses: A Systematic Review and a Survey of Patient and Clinician Priorities. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.02.008: Outcome Prediction in Localised Renal Cancer: We Need to Do BetterEduard Roussel, Daniele Amparore, Maarten Albersen
Pageof 32

Showing results (1-10 of 319) with videos related to

Sort By:
Pageof 32
International Journal of Urology : Official Journal of the Japanese Urological Association|November 5, 2021
Editorial Comment to Randomized trials to determine the ideal management of the renal artery during partial nephrectomy: Life's under no obligation to give us what we expectRiccardo Campi, Daniele Amparore,
The Lancet. Oncology|May 4, 2023
Fluorescence in prostate cancer surgeryDaniele Amparore, Francesco Porpiglia
Asian Journal of Urology|February 1, 2023
Reply to Grange PC, Morris PT, Benz HL, Buggele WA, Fryrear RS. Letter to the editor re: Amparore D, Pecoraro A, Piramide F, Verri P, Checcucci E, De Cillis S, et al. Three-dimensional imaging reconstruction of the kidney's anatomy for a tailored minimally invasive partial nephrectomy: A pilot study. Asian J Urol 2022;9:263-71. A further step towards personalized surgery through virtual clip applicationAngela Pecoraro, Daniele Amparore
Nature Reviews. Urology|April 29, 2026
Adjuvant immunotherapy for renal cell carcinoma: understanding complexity, embracing uncertainty, making a differenceRiccardo Campi, Daniele Amparore,
European Urology|October 17, 2019
Re: Partial Nephrectomy Versus Radical Nephrectomy for cT2 or Greater Renal Tumors: A Systematic Review and Meta-analysisFrancesco Porpiglia, Daniele Amparore
Current Opinion in Urology|August 3, 2013
Treatment outcomes of partial nephrectomy for T1b tumoursAlessandro Volpe, Daniele Amparore, Alexandre Mottrie
Minerva Urology and Nephrology|September 25, 2024
YAU Renal Cancer spotlight - Hugo RAS platform for robotic partial nephrectomy: more evidence neededRiccardo Bertolo, Riccardo Campi, Daniele Amparore, et al.
Minerva Urology and Nephrology|June 18, 2025
YAU-RCC Spotlight: can we train immunity to cure RCC? Lessons from a neoantigen vaccine trialVeronica Mollica, Riccardo Campi, Daniele Amparore, et al.
Minerva Urology and Nephrology|June 18, 2025
YAU renal cancer SPOTLIGHT: the understated challenge of tumor rupture during robotic partial nephrectomyRiccardo Bertolo, Riccardo Campi, Daniele Amparore, et al.
European Urology Oncology|March 25, 2026
Re: Blackmur JP, Rossi SH, Kuusk T, et al. Prediction Models for Shared Decision-making by Patients with Localised Renal Masses: A Systematic Review and a Survey of Patient and Clinician Priorities. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.02.008: Outcome Prediction in Localised Renal Cancer: We Need to Do BetterEduard Roussel, Daniele Amparore, Maarten Albersen
Pageof 32